Erhe Gao Selected Research

G-Protein-Coupled Receptor Kinase 5

1/2022	G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
12/2015	Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy.
12/2013	Regulation of nuclear factor κB (NF-κB) in the nucleus of cardiomyocytes by G protein-coupled receptor kinase 5 (GRK5).
9/2012	Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erhe Gao Research Topics

Disease

63	Myocardial Infarction 03/2021 - 09/2004
53	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 03/2002
41	Infarction (Infarctions) 01/2021 - 10/2003
40	Heart Failure 01/2022 - 09/2006
33	Reperfusion Injury 01/2021 - 05/2002
28	Ischemia 12/2021 - 05/2002
17	Fibrosis (Cirrhosis) 01/2021 - 10/2003
13	Hypertrophy 01/2022 - 05/2010
13	Cardiomegaly (Heart Hypertrophy) 01/2022 - 08/2008
13	Hypoxia (Hypoxemia) 01/2021 - 09/2003
12	Inflammation (Inflammations) 11/2021 - 12/2010
7	Cardiomyopathies (Cardiomyopathy) 01/2021 - 09/2006
6	Heart Injuries 01/2022 - 02/2009
5	Neoplasms (Cancer) 01/2022 - 07/2012
5	Atherosclerosis 12/2020 - 12/2003
4	Insulin Resistance 01/2021 - 05/2011
4	Heart Diseases (Heart Disease) 09/2020 - 02/2009
4	Ventricular Remodeling 09/2017 - 01/2012
4	Myocardial Reperfusion Injury 03/2015 - 05/2002
3	Type 2 Diabetes Mellitus (MODY) 11/2021 - 03/2007
3	Body Weight (Weight, Body) 01/2020 - 10/2003
3	Left Ventricular Dysfunction 02/2019 - 07/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2012
2	Diabetic Cardiomyopathies 11/2021 - 09/2017
2	Cicatrix (Scar) 12/2020 - 10/2018
2	Necrosis 01/2019 - 05/2014
2	Hypertension (High Blood Pressure) 01/2018 - 01/2017
2	Teratoma (Teratoid Tumor) 01/2018 - 06/2015
2	Ventricular Dysfunction 01/2016 - 01/2012
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2016 - 02/2012

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 12/2021 - 03/2007
12	AdiponectinIBA 01/2018 - 03/2007
9	Phosphotransferases (Kinase)IBA 01/2021 - 08/2008
9	Small Interfering RNA (siRNA)IBA 01/2020 - 10/2012
8	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2003
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 12/2010
8	G-Protein-Coupled Receptor Kinase 2IBA 01/2017 - 08/2008
7	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 10/2010
7	MelatoninIBA 01/2020 - 01/2016
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2011
6	Caspase 3 (Caspase-3)IBA 04/2014 - 08/2004
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2010 - 03/2002
5	Peptides (Polypeptides)IBA 01/2021 - 08/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 06/2012
5	Tamoxifen FDA LinkGeneric 11/2019 - 08/2008
5	AdipokinesIBA 08/2019 - 08/2011
5	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2018 - 10/2010
5	Superoxides (Superoxide)IBA 01/2018 - 03/2007
4	G-Protein-Coupled Receptor Kinase 5IBA 01/2022 - 09/2012
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 09/2017
4	AMP-Activated Protein KinasesIBA 01/2019 - 02/2009
4	Insulin (Novolin)FDA Link 12/2015 - 03/2002
4	Peroxynitrous Acid (Peroxynitrite)IBA 03/2009 - 08/2006
3	Adiponectin ReceptorsIBA 01/2022 - 09/2011
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 01/2013
3	Azithromycin (Zithromax)FDA LinkGeneric 03/2021 - 01/2018
3	CatecholaminesIBA 01/2021 - 05/2010
3	Messenger RNA (mRNA)IBA 01/2021 - 05/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2020 - 04/2013
3	CateninsIBA 01/2020 - 02/2012
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 12/2003
3	Protein Isoforms (Isoforms)IBA 01/2016 - 02/2014
3	beta Adrenergic ReceptorsIBA 10/2015 - 08/2006
3	Etanercept (Enbrel)FDA Link 06/2015 - 08/2011
3	Glycogen Synthase (Synthase I)IBA 01/2014 - 05/2010
3	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2013 - 03/2009
3	ThioredoxinsIBA 10/2012 - 08/2004
3	Adrenergic Agents (Adrenergic Drugs)IBA 05/2011 - 05/2005
3	Rosiglitazone (Avandia)FDA Link 03/2010 - 04/2004
3	PPAR-gamma AgonistsIBA 02/2010 - 12/2003
2	InflammasomesIBA 12/2021 - 01/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2020
2	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 07/2007
2	Peptide Hydrolases (Proteases)FDA Link 12/2020 - 01/2005
2	CaspasesIBA 12/2020 - 01/2005
2	Phosphates (Orthophosphate)IBA 12/2020 - 11/2019
2	Branched-Chain Amino AcidsIBA 01/2020 - 11/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2019
2	HydrogelsIBA 01/2020 - 10/2018
2	Circular RNAIBA 01/2020 - 01/2019
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2020 - 09/2013
2	Angiotensin IIIBA 01/2019 - 01/2018
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019 - 09/2012
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 01/2018
2	Atrial Natriuretic Factor (ANF)IBA 01/2019 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2013
2	Conditioned Culture MediaIBA 01/2018 - 06/2012
2	CytokinesIBA 01/2018 - 08/2014
2	Sirtuin 3IBA 09/2017 - 09/2017
2	Glycogen Synthase Kinase 3IBA 01/2016 - 07/2010
2	transcription factor NF-AT c3IBA 10/2015 - 12/2014
2	Pharmaceutical PreparationsIBA 11/2014 - 04/2014
2	phospholemmanIBA 04/2014 - 02/2012
2	AldosteroneIBA 02/2014 - 09/2013

Therapy/Procedure

23	Therapeutics 01/2022 - 05/2007
13	Ligation 01/2021 - 10/2003
6	Transplantation 01/2020 - 09/2004
2	Injections 01/2021 - 01/2018
2	Cell Transplantation 10/2018 - 06/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2017 - 01/2016